160 related articles for article (PubMed ID: 16940392)
1. Implantation of paclitaxel-eluting stents in saphenous vein grafts: clinical and angiographic follow-up results from a multicentre study.
Hoffmann R; Pohl T; Köster R; Blindt R; Boeckstegers P; Heitzer T
Heart; 2007 Mar; 93(3):331-4. PubMed ID: 16940392
[TBL] [Abstract][Full Text] [Related]
2. A randomized controlled trial of a paclitaxel-eluting stent versus a similar bare-metal stent in saphenous vein graft lesions the SOS (Stenting of Saphenous Vein Grafts) trial.
Brilakis ES; Lichtenwalter C; de Lemos JA; Roesle M; Obel O; Haagen D; Saeed B; Gadiparthi C; Bissett JK; Sachdeva R; Voudris VV; Karyofillis P; Kar B; Rossen J; Fasseas P; Berger P; Banerjee S
J Am Coll Cardiol; 2009 Mar; 53(11):919-28. PubMed ID: 19281920
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the slow-release polymer-based paclitaxel-eluting Taxus-Express stent with the bare-metal Express stent for saphenous vein graft interventions.
Wöhrle J; Nusser T; Kestler HA; Kochs M; Hombach V
Clin Res Cardiol; 2007 Feb; 96(2):70-6. PubMed ID: 17146605
[TBL] [Abstract][Full Text] [Related]
4. Clinical presentation and angiographic characteristics of saphenous vein graft failure after stenting: insights from the SOS (stenting of saphenous vein grafts) trial.
Lichtenwalter C; de Lemos JA; Roesle M; Obel O; Holper EM; Haagen D; Saeed B; Iturbe JM; Shunk K; Bissett JK; Sachdeva R; Voudris VV; Karyofillis P; Kar B; Rossen J; Fasseas P; Berger P; Banerjee S; Brilakis ES
JACC Cardiovasc Interv; 2009 Sep; 2(9):855-60. PubMed ID: 19778774
[TBL] [Abstract][Full Text] [Related]
5. Continued benefit from paclitaxel-eluting compared with bare-metal stent implantation in saphenous vein graft lesions during long-term follow-up of the SOS (Stenting of Saphenous Vein Grafts) trial.
Brilakis ES; Lichtenwalter C; Abdel-karim AR; de Lemos JA; Obel O; Addo T; Roesle M; Haagen D; Rangan BV; Saeed B; Bissett JK; Sachdeva R; Voudris VV; Karyofillis P; Kar B; Rossen J; Fasseas P; Berger P; Banerjee S
JACC Cardiovasc Interv; 2011 Feb; 4(2):176-82. PubMed ID: 21349456
[TBL] [Abstract][Full Text] [Related]
6. Randomized double-blind comparison of sirolimus-eluting stent versus bare-metal stent implantation in diseased saphenous vein grafts: six-month angiographic, intravascular ultrasound, and clinical follow-up of the RRISC Trial.
Vermeersch P; Agostoni P; Verheye S; Van den Heuvel P; Convens C; Bruining N; Van den Branden F; Van Langenhove G
J Am Coll Cardiol; 2006 Dec; 48(12):2423-31. PubMed ID: 17174178
[TBL] [Abstract][Full Text] [Related]
7. Treatment of saphenous vein graft lesions with drug-eluting stents: immediate and midterm outcome.
Ge L; Iakovou I; Sangiorgi GM; Chieffo A; Melzi G; Cosgrave J; Montorfano M; Michev I; Airoldi F; Carlino M; Corvaja N; Colombo A
J Am Coll Cardiol; 2005 Apr; 45(7):989-94. PubMed ID: 15808752
[TBL] [Abstract][Full Text] [Related]
8. Recurrent cardiovascular events with paclitaxel-eluting versus bare-metal stents in saphenous vein graft lesions: insights from the SOS (Stenting of Saphenous Vein Grafts) trial.
Michael TT; Abdel-karim AR; Papayannis A; Lichtenwalter C; de Lemos JA; Obel O; Addo T; Roesle M; Haagen D; Rangan BV; Saeed B; Bissett JK; Sachdeva R; Voudris VV; Karyofillis P; Kar B; Rossen J; Fasseas P; Berger PB; Banerjee S; Brilakis ES
J Invasive Cardiol; 2011 Jun; 23(6):216-9. PubMed ID: 21646644
[TBL] [Abstract][Full Text] [Related]
9. Comparison of sirolimus-eluting stents with paclitaxel-eluting stents in saphenous vein graft intervention (from a multicenter Southern California Registry).
Lee MS; Hu PP; Aragon J; Shah AP; Oyama J; Dhoot J; Iqbal Z; Jones N; Penny W; Tobis J; Mahmud E; French W
Am J Cardiol; 2010 Aug; 106(3):337-41. PubMed ID: 20643242
[TBL] [Abstract][Full Text] [Related]
10. Comparison of sirolimus-eluting stent, paclitaxel-eluting stent, and bare metal stent in the treatment of long coronary lesions.
Kim YH; Park SW; Lee CW; Hong MK; Gwon HC; Jang Y; Lee MM; Koo BK; Oh DJ; Seung KB; Tahk SJ; Yoon J; Park SJ
Catheter Cardiovasc Interv; 2006 Feb; 67(2):181-7. PubMed ID: 16400663
[TBL] [Abstract][Full Text] [Related]
11. Comparison of plaque sealing with paclitaxel-eluting stents versus medical therapy for the treatment of moderate nonsignificant saphenous vein graft lesions: the moderate vein graft lesion stenting with the taxus stent and intravascular ultrasound (VELETI) pilot trial.
Rodés-Cabau J; Bertrand OF; Larose E; Déry JP; Rinfret S; Bagur R; Proulx G; Nguyen CM; Côté M; Landcop MC; Boudreault JR; Rouleau J; Roy L; Gleeton O; Barbeau G; Noël B; Courtis J; Dagenais GR; Després JP; DeLarochellière R
Circulation; 2009 Nov; 120(20):1978-86. PubMed ID: 19884468
[TBL] [Abstract][Full Text] [Related]
12. Impact of post-intervention minimal stent area on 9-month follow-up patency of paclitaxel-eluting stents: an integrated intravascular ultrasound analysis from the TAXUS IV, V, and VI and TAXUS ATLAS Workhorse, Long Lesion, and Direct Stent Trials.
Doi H; Maehara A; Mintz GS; Yu A; Wang H; Mandinov L; Popma JJ; Ellis SG; Grube E; Dawkins KD; Weissman NJ; Turco MA; Ormiston JA; Stone GW
JACC Cardiovasc Interv; 2009 Dec; 2(12):1269-75. PubMed ID: 20129555
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of a new polymer-coated paclitaxel-eluting stent for treatment of de novo lesions: six-month clinical and angiographic follow-up results of the APPLAUSE trial.
Grube E; Mueller R; Lim V; Schmidt T; Gerckens U; Buellesfeld L
J Invasive Cardiol; 2006 May; 18(5):194-8. PubMed ID: 16670444
[TBL] [Abstract][Full Text] [Related]
14. Long-term clinical benefit of sirolimus-eluting stents compared to bare metal stents in the treatment of saphenous vein graft disease.
Minutello RM; Bhagan S; Sharma A; Slotwiner AJ; Feldman DN; Cuomo LJ; Wong SC
J Interv Cardiol; 2007 Dec; 20(6):458-65. PubMed ID: 18042050
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of sirolimus-eluting stents as compared to paclitaxel-eluting stents for saphenous vein graft intervention.
Chu WW; Kuchulakanti PK; Wang B; Clavijo LC; Suddath WO; Pichard AD; Satler LF; Kent KM; Waksman R
J Interv Cardiol; 2006 Apr; 19(2):121-5. PubMed ID: 16650239
[TBL] [Abstract][Full Text] [Related]
16. Everolimus-eluting stents compared with paclitaxel-eluting stents for treatment of coronary in-stent restenoses.
Markovic S; Paliskyte R; Rottbauer W; Wöhrle J
Cardiovasc Revasc Med; 2012; 13(6):307-10. PubMed ID: 23164475
[TBL] [Abstract][Full Text] [Related]
17. 5-year follow-up of polytetrafluoroethylene-covered stents compared with bare-metal stents in aortocoronary saphenous vein grafts the randomized BARRICADE (barrier approach to restenosis: restrict intima to curtail adverse events) trial.
Stone GW; Goldberg S; O'Shaughnessy C; Midei M; Siegel RM; Cristea E; Dangas G; Lansky AJ; Mehran R
JACC Cardiovasc Interv; 2011 Mar; 4(3):300-9. PubMed ID: 21435608
[TBL] [Abstract][Full Text] [Related]
18. A multicenter randomized comparison of drug-eluting balloon plus bare-metal stent versus bare-metal stent versus drug-eluting stent in bifurcation lesions treated with a single-stenting technique: six-month angiographic and 12-month clinical results of the drug-eluting balloon in bifurcations trial.
Stella PR; Belkacemi A; Dubois C; Nathoe H; Dens J; Naber C; Adriaenssens T; van Belle E; Doevendans P; Agostoni P
Catheter Cardiovasc Interv; 2012 Dec; 80(7):1138-46. PubMed ID: 22422607
[TBL] [Abstract][Full Text] [Related]
19. Polymer-based paclitaxel-eluting stents are superior to nonpolymer-based paclitaxel-eluting stents in the treatment of de novo coronary lesions.
Iofina E; Langenberg R; Blindt R; Kühl H; Kelm M; Hoffmann R
Am J Cardiol; 2006 Oct; 98(8):1022-7. PubMed ID: 17027564
[TBL] [Abstract][Full Text] [Related]
20. Treatment of in-stent restenosis using a paclitaxel-eluting stent: acute results and long-term follow-up of a matched-pair comparison with intracoronary beta-radiation therapy.
Radke PW; Kobella S; Kaiser A; Franke A; Schubert D; Grube E; Hanrath P; Hoffmann R
Eur Heart J; 2004 Jun; 25(11):920-5. PubMed ID: 15172463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
